查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1406988

分子機器人：市場佔有率分析、產業趨勢/統計、成長預測，2024-2029

Molecular Robotics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2024 - 2029
出版日期: | 出版商: Mordor Intelligence | 英文 119 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

分子機器人市場預計在預測期內複合年成長率為 18%。

COVID-19 爆發後，所有市場都因供應鏈中斷而受到重大影響。然而，尋找 COVID-19 感染潛在治療方法的研發工作活性化。分子機器人研究和開發的需求量很大，因為改變分子可以提供更快、更聰明的治療選擇。為了找到更好的患者護理和治療方法，已經進行了許多研究。 2021年8月發表在《英國醫學雜誌》上的一篇論文指出，研究人員開發了一種機器人核酸萃取方法，用於高通量檢測唾液樣本中的SARS-CoV-2 RNA。此外，正在進行進一步的研究以尋找 COVID-19 的治療方法。這些研究和研究正在創造對分子機器人的需求，並對目標市場產生積極影響。然而，由於活性化，市場目前正在穩步成長，並且預計未來幾年將繼續保持相同的趨勢。

癌症和其他罕見疾病等慢性疾病的高盛行率以及藥物開發中利用率的增加是分子機器人市場的主要促進因素。例如，根據 2021 年乳癌概況介紹，英國每年約有 55,000 名女性和 370 名男性被診斷出罹患乳癌。到 2030 年，這一數字預計將增至 120 萬。癌症發生率的增加促使對先進技術的需求增加。對分子機器人技術的需求正在增加，並且可以預測，因為它們可以讀取、編輯和修改 DNA 和 RNA，創造新的結構來尋找癌症等疾病的治療方法。預計在此期間市場將會成長。

分子機器人-市場-IMG1

如今，研究和開發不斷增加，實驗室自動化已成為維持平穩工作流程的必要條件。分子機器人採用先進技術設計，可最大程度地減少學習新軟體和其他設備的壓力，使科學家能夠提高實驗室的整體效率並加速下一代研究。 2022年7月，調查團隊開發出一種新型DNA馬達，可以感知和處理化學資訊。隨著新研究創造出第一個基於 DNA 的電機，該電機將運算能力與燃燒燃料和朝著有目的的方向移動的能力結合在一起，小分子機器人技術的靈感正在飛速成長。預計這將在預測期內抓住需求並促進所研究市場的成長。

然而，這些分子機器人的市場開拓和設計成本高昂，預計將限制研究預測期內的市場成長。

分子機器人市場趨勢

依應用領域分類的藥物研發預計將在預測期內實現健康成長

分子奈米技術的快速發展為分子機器人等先進技術打開了大門。這項技術使用分子作為機器人的一部分。由於慢性病和罕見疾病的增加，對藥物研發的需求不斷增加。由於藥物研發需要時間，研究人員現在專注於像機器人一樣處理分子，並將分子機器人技術涵蓋藥物研發平台。

根據 2021 年 2 月發表在 Springer Nature 分子機器人雜誌上的一項研究，DNA 奈米技術的進步正在增加對由生物分子製成的分子機器人的需求。同一消息來源還指出，這些分子機器人可以提供具有先進資訊處理能力的藥物，也可以用於治療治療診斷學（用於治療和診斷的術語）。因此，研發的擴大以及分子機器人在藥物研發中的應用正在增加對分子機器人的需求，並有望支持該領域研究市場的成長。

應用生物分子機器人技術的藥物研發發現領域的實驗、臨床試驗和資金籌措的增加目前正在促進研究市場的成長。例如，2022年6月，Insilico Medical宣布完成6,000萬美元的D輪資金籌措，投資方為具有生物製藥和生命科學產業投資經驗的全球投資者企業聯合組織。這筆資金籌措的目的是投資推出一個由人工智慧驅動的藥物研發機器人實驗室，以建構具有所需功能的獨特分子結構。

因此，研究機構和主要市場參與者的活動不斷增加正在推動藥物研發領域的成長。預計這將有助於預測期內研究市場的成長。

分子機器人-市場-IMG2

北美佔據市場主要佔有率，預計在預測期內將成長

北美在分子機器人市場中佔據主導地位，由於先進的機器人技術和製藥領域的活性化，預計該地區的市場將成長。北美最近癌症和其他罕見疾病等慢性病的盛行率上升。北美，特別是美國正在進行研究工作，以發現更好、更先進的藥物和治療方法。

根據美國癌症協會2023年1月發布的《2023年癌症事實與數據》，預計2023年將有190萬新癌症患者被診斷出來，其中288,300人被診斷為前列腺癌，其次是肺癌，預計238,340人被診斷為前列腺癌。人們患有乳腺癌，其中 305,590 名女性患有乳腺癌。此外，根據加拿大政府2022年5月發布的統計數據，2022年將有約233,900名加拿大人被診斷出患有癌症，其中前列腺癌預計仍將是最常診斷出的癌症。癌症病例促使美國研究機構與其他北美國家的研究機構合作。這項合作涉及尋找癌症的最佳治療方法。分子機器人技術是該地區研究最多的癌症藥物研發發現研究工具之一。

北美地區市場參與企業高度集中，這些公司推出的新產品也支持該地區的市場成長。大學積極參與藥物研發研究和分子機器人技術也支持了研究市場的成長。例如，2021年11月，哈佛大學維斯仿生工程研究所與佛蒙特大學和塔夫茨大學一起宣布，以創造第一個活體機器人而聞名的研究團隊宣布發現了一種科學的繁殖型態，為再生醫學的發展帶來了許多機會。預計該地區的先進研究和開發將在預測期內推動研究市場的成長。

分子機器人產業概述

分子機器人市場的競爭是溫和的。目前主導該市場的公司包括丹納赫公司（醫療器材有限責任公司）、布魯克、賽默飛世爾科技、Qiagen、珀金埃爾默公司和 Zymergen 公司。這些大公司在產業中佔有很大的佔有率。大多數公司專注於將技術先進的產品推向市場，以獲得最大的市場佔有率。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場促進因素
    • 研發投入增加，機器人技術進步
    • 擴大用於罕見疾病的藥物開發
  • 市場抑制因素
    • 機器人設計與製造成本急劇上升
  • 波特五力分析
    • 新進入者的威脅
    • 買家/消費者的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間敵對關係的強度

第5章市場區隔

  • 依產品類型
    • 軟體和耗材
    • 裝置
  • 依用途
    • 藥物研發
    • 基因研究
    • 其他
  • 依最終用戶
    • 研究機構
    • 製藥和生物技術公司
  • 依地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 其他歐洲國家
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 其他亞太地區
    • 中東/非洲
      • GCC
      • 南非
      • 其他中東/非洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區

第6章 公司概況及競爭形勢

  • 公司簡介
    • Bruker
    • Danaher Corporation（Medical Devices, LLC.）
    • Entos, Inc.
    • Hudson Robotics
    • Imina Technologies SA
    • International Business Machines Corporation（IBM）
    • Klocke Nanotechnik GmbH
    • Labplan
    • Nanorobotics Ltd.
    • PerkinElmer Inc.
    • Qiagen
    • Thermo Fisher Scientific
    • Zymergen Inc.

第7章 市場機會及未來趨勢

簡介目錄
Product Code: 90444
Molecular Robotics - Market - IMG1

The molecular robotics market is expected to witness a CAGR of 18% over the forecast period.

After the outbreak of COVID-19, all markets were significantly affected due to supply chain disruptions. However, research and development were increased to find potential treatments for the COVID-19 infection. The demand for research and development in molecular robotics has increased because it can enable fast and smart treatment options by changing molecules. Many research studies have been conducted to find better patient care and treatment options. In an article published in the British Medical Journal in August 2021, it was mentioned that researchers developed a robotic nucleic acid extraction method for high-throughput detection of SARS-CoV-2 RNA in saliva samples. More research and studies have also been done to find a cure for COVID-19. These research and studies have created a demand for molecular robots and have had a positive impact on the market under review. However, currently, the market is growing at a stable pace owing to rising research and development activities, and it is expected to witness a similar trend over the coming years.

The high prevalence of chronic diseases such as cancer and other rare diseases and increased use in drug development are the major driving factors for the molecular robotics market. For instance, according to the Breast Cancer Factsheet Now 2021, around 55,000 women and 370 men in the United Kingdom are diagnosed with breast cancer every year. This figure is expected to climb to 1.2 million by 2030. This rising incidence of cancer leads to increased demand for advanced technology. As molecular robots can read, edit, and alter DNA and RNA, which can create new structures to find a cure for cancer-like diseases, the demand for these molecular robots is increasing, which is expected to lead to the growth of the market during the forecast period.

As research and development have been on the rise lately, laboratory automation is becoming a need to maintain a smooth workflow. Molecular robots are designed using advanced technologies to minimize the pressure of learning new software and other equipment, helping scientists increase the overall efficiency of their laboratories and accelerate next-generation research. In July 2022, Researchers created new DNA motors that can sense and process chemical information, allowing them to respond quickly and mimic some fundamental properties of living cells. With new research producing the first DNA-based motors that combine computational power with the ability to burn fuel and move in an intentional direction, the inspiration for miniature molecular robots is rising exponentially. This is expected to gain demand and boost the growth of the studied market during the forecast period.

However, the high cost of development and design of these molecular robots is expected to restrain the growth of the market over the studied forecast period.

Molecular Robotics Market Trends

Drug Discovery by the Application Segment is Expected to Witness a Healthy Growth Over the Forecast Period

The rapid progress of molecular nanotechnology has opened the door to advanced technologies such as molecular robotics. This technique uses molecules as parts of robots. Drug discovery has gained demand due to the increasing incidence of chronic and rare diseases. Because drug discovery takes time, researchers are now focusing on using molecules as robots and introducing molecular robotics into the drug discovery platform.

According to the study published in Springer Nature's Molecular Robotics in February 2021, advances in DNA nanotechnology are increasing the demand for molecular robots made of biomolecules. The same source also stated that these molecular robots can carry drugs with sophisticated information processing capabilities and can also be used for theranostics (a term used for therapy and diagnosis). This growing R&D in drug discovery and the application of molecular robotics in drug discovery are increasing the demand for molecular robots, which is expected to boost the growth of the studied market in this segment.

The increasing number of experiments, clinical trials, and fundraisers in the field of drug discovery for the application of biomolecular robots is currently increasing the growth of the studied market. For instance, in June 2022, Insilico Medical announced the completion of a USD 60 million Series D fundraising from a syndicate of global investors with experience investing in the biopharmaceutical and life sciences industries. The funding aims to invest in the launch of an AI-powered drug discovery robotics laboratory and construct unique molecular structures with desired features.

Therefore, the increasing activities by the research organizations and the major market players are driving the growth of the drug discovery segment. This is expected to contribute to the studied market's growth over the forecast period.

Molecular Robotics - Market - IMG2

North America Holds Significant Share in the Market and Expected to Grow in Forecast Period

North America is expected to dominate the molecular robotics market, and the market is expected to grow in the region due to advanced robotics technologies and increased research and developments in the pharmaceutical sector. The prevalence of chronic diseases, such as cancer and other rare diseases, has recently been increasing in North America. In North America, especially in the United States, research and studies are leaning toward finding better and more advanced drug and treatment options.

According to Cancer Facts and Figures 2023, published in January 2023 by the American Cancer Society, an estimated 1.9 million new cancer cases will be diagnosed in 2023, among which prostate cancer is estimated to be among 288,300, followed by 238.340 cases of lung cancer and 300,590 cases of female breast cancer. Furthermore, according to statistics published by the Government of Canada and released in May 2022, about 233,900 Canadians were diagnosed with cancer in 2022, and prostate cancer is expected to remain the most commonly diagnosed cancer. Cancer cases motivate research institutes in the United States to collaborate with research institutes in other North American countries. This collaboration is involved in finding the best cure for cancer. Molecular robots are one of the most studied tools for cancer drug discovery research in the region.

The presence of a high concentration of market players in the North American region and new product launches by these players are also driving the growth of the market in the region. Active participation of universities in drug research and molecular robotics is also supporting the growth of the studied market. For instance, in November 2021, Harvard University's Wyss Institute for Biologically Inspired Engineering, along with the University of Vermont and Tufts University, announced that a team of researchers known to have built the first living robot, the Xenobot, had discovered an entirely new form of biological reproduction of this living robot, which promises numerous opportunities for regenerative medicine development. The advanced research and developments in the region are anticipated to spur the growth of the studied market over the forecast period.

Molecular Robotics Industry Overview

The molecular robotics market is moderately competitive. Some of the companies currently dominating the market are Danaher Corporation (Medical Devices LLC), Bruker, Thermo Fisher Scientific, Qiagen, PerkinElmer Inc., and Zymergen Inc., among others. These major players hold a significant share in the industry. Most of the players focus on bringing technologically advanced products into the market to acquire the maximum market share.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing R&D Investment and Advancements in Robotics Technology
    • 4.2.2 Increased Use in Drug Development for Rare Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Moecular Robots Designing and Production
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Million)

  • 5.1 By Product Type
    • 5.1.1 Software and Consumables
    • 5.1.2 Devices
  • 5.2 By Application
    • 5.2.1 Drug Discovery
    • 5.2.2 Genetic Research
    • 5.2.3 Others
  • 5.3 By End-User
    • 5.3.1 Research Laboratories
    • 5.3.2 Pharma and Biotech Companies
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPANY PROFILES AND COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bruker
    • 6.1.2 Danaher Corporation (Medical Devices, LLC.)
    • 6.1.3 Entos, Inc.
    • 6.1.4 Hudson Robotics
    • 6.1.5 Imina Technologies SA
    • 6.1.6 International Business Machines Corporation (IBM)
    • 6.1.7 Klocke Nanotechnik GmbH
    • 6.1.8 Labplan
    • 6.1.9 Nanorobotics Ltd.
    • 6.1.10 PerkinElmer Inc.
    • 6.1.11 Qiagen
    • 6.1.12 Thermo Fisher Scientific
    • 6.1.13 Zymergen Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS